Development of Antiviral Innate Immunity during in Vitro Differentiation of Mouse Embryonic Stem Cells

Stem Cells and Development

Volumn 25, Issue 8, 2016, Pages 648-659

  D'Angelo, William ^a   Acharya, Dhiraj ^a   Wang, Ruoxing ^b   Wang, Jundi ^a   Gurung, Chandan ^a   Chen, Bohan ^a   Bai, Fengwei ^a   Guo, Yan Lin ^a  

^a University of Southern Mississippi   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON;

ANIMAL CELL; ANTIVIRAL INNATE IMMUNITY; ARTICLE; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; FIBROBLAST; IN VITRO PROPAGATION; IN VITRO STUDY; INNATE IMMUNITY; MOUSE; MOUSE EMBRYONIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; ANIMAL; CELL LINE; CHIKUNGUNYA VIRUS; CHLOROCEBUS AETHIOPS; COCULTURE; IMMUNOLOGY; LA CROSSE VIRUS; METABOLISM; PHYSIOLOGY; REGENERATIVE MEDICINE; VERO CELL LINE; VIROLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CERCOPITHECUS AETHIOPS; CHIKUNGUNYA VIRUS; COCULTURE TECHNIQUES; IMMUNITY, INNATE; INTERFERON TYPE I; LA CROSSE VIRUS; MICE; MOUSE EMBRYONIC STEM CELLS; NF-KAPPA B; REGENERATIVE MEDICINE; VERO CELLS;

EID: 84964900452     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0377     Document Type: Article

References (50)

1. Wobus AM and KR Boheler. (2005). Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol Rev 85:635-678.
2. Keller G. (2005). Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev 19:1129-1155.
3. Foldes G, A Liu, R Badiger, M Paul-Clark, L Moreno, Z Lendvai, JS Wright, NN Ali, SE Harding and JA Mitchell. (2010). Innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS One 5:e10501.
4. Zampetaki A, Q Xiao, L Zeng, Y Hu and Q Xu. (2006). TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. Biochem Biophys Res Commun 347:89-99.
5. Glaser DE, RM Gower, NE Lauer, K Tam, AA Blancas, AJ Shih, SI Simon and KE McCloskey. (2011). Functional characterization of embryonic stem cell-derived endothelial cells. J Vasc Res 48:415-428.
6. Rajan R, J Ye, S Bai, F Huang and YL Guo. (2008). NF-kB, but not p38 MAP Kinase, is required for TNF-a-induced expression of cell adhesion molecules in endothelial cells. J Cell Biochem 105:477-486.
7. Sen GC. (2001). Viruses and infections. Annu Rev Microbiol 55:255-281.
8. Chen LL, L Yang and GG Carmichael. (2010). Molecular basis for an attenuated cytoplasmic dsRNA response in human embryonic stem cells. Cell Cycle 9:3552-3564.
9. Yu J, R Rossi, C Hale, D Goulding and G Dougan. (2009). Interaction of enteric bacterial pathogens with murine embryonic stem cells. Infect Immunity 77:585-597.
10. Wash R, S Calabressi, S Franz, SJ Griffiths, D Goulding, EP Tan, H Wise, P Digard, J Haas, S Efstathiou and P Kellam. (2012). Permissive and restricted virus infection of murine embryonic stem cells. J Gen Virol 93:2118-2130.
11. Wang R, C Teng, J Spangler, J Wang, F Huang and Y-L Guo. (2014). Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy. Stem Cells Dev 23:594-604.
12. Wang R, J Wang, AM Paul, D Acharya, F Bai, F Huang and YL Guo. (2013). Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA. J Biol Chem 288: 15926-15936.
13. Wang R, J Wang, D Acharya, AM Paul, F Bai, F Huang and YL Guo. (2014). Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response. J Biol Chem 289:25186-25198.
14. Samuel CE. (2001). Antiviral actions of interferons. Clin Microbiol Rev 14:778-809.
15. Chen GY, SM Hwang, HJ Su, CY Kuo, WY Luo, KW Lo, CC Huang, CL Chen, SH Yu and YC Hu. (2012). Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. J Virol 86:8041-8049.
16. Harada H, K Willison, J Sakakibara, M Miyamoto, T Fujita and T Taniguchi. (1990). Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63:303-312.
17. Guo YL, GG Carmichael, R Wang, X Hong, D Acharya, F Huang and F Bai. (2015). Attenuated innate immunity in embryonic stem cells and its implications in developmental biology and regenerative medicine. Stem Cells 33:3165-3173.
18. Levy O. (2007). Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379-390.
19. Garcia MA, EF Meurs and M Esteban. (2007). The dsRNA protein kinase PKR: Virus and cell control. Biochimie 89: 799-811.
20. Maillard PV, C Ciaudo, A Marchais, Y Li, F Jay, SW Ding and O Voinnet. (2013). Antiviral RNA interference in mammalian cells. Science 342:235-238.
21. Pare JM and CS Sullivan. (2014). Distinct antiviral responses in pluripotent versus differentiated cells. PLoS Pathog 10: e1003865.
22. Cullen BR, S Cherry and BR tenOever. (2013). Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 14:374-378.
23. Li Y, J Lu, Y Han, X Fan and SW Ding. (2013). RNA interference functions as an antiviral immunity mechanism in mammals. Science 342:231-234.
24. Guo YL, J Ye and F Huang. (2007). p38alpha MAP kinasedeficient mouse embryonic stem cells can differentiate to endothelial cells, smooth muscle cells, and neurons. Dev Dyn 236:3383-3392.
25. Guo YL, S Chakraborty, S Rajan, R Wang and F Huang. (2010). Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and self-Renewal. Stem Cells Dev 19:1321-1331.
26. Bai F, T Wang, U Pal, F Bao, LH Gould and E Fikrig. (2005). Use of RNA interference to prevent lethal murine west nile virus infection. J Infect Dis 191:1148-1154.
27. Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucl Acids Res 29:e45.
28. Soldan SS, BS Hollidge, V Wagner, F Weber and F Gonzalez-Scarano. (2010). La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic. Virology 404:139-147.
29. Pinney DF and CP Emerson Jr. (1989). 10T1/2 Cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ Health Perspect 80:221-227.
30. Reznikoff CA, DW Brankow and C Heidelberger. (1973). Establishment and characterization of a cloned line of c3h mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33:3231-3238.
31. Pan ZK, C Fisher, JD Li, Y Jiang, S Huang and LY Chen. (2011). Bacterial LPS up-regulated TLR3 expression is critical for antiviral response in human monocytes: evidence for negative regulation by CYLD. Int Immunol 23: 357-364.
32. Matsumoto M and T Seya. (2008). TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 60:805-812.
33. Huang CC, KE Duffy, LR San Mateo, BY Amegadzie, RT Sarisky and ML Mbow. (2006). A pathway analysis of poly(I:C)-induced global gene expression change in human peripheral blood mononuclear cells. Physiol Genomics 26: 125-133.
34. Kawai T and S Akira. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637-650.
35. Yoneyama M and T Fujita. (2007). Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 282: 15315-15318.
36. de Veer MJ, M Holko, M Frevel, E Walker, S Der, JM Paranjape, RH Silverman and BRG Williams. (2001). Functional classification of interferon-stimulated genes identified using microarrays. J Leuk Biol 69:912-920.
37. Gil JS and M Esteban. (2000). Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5:107-114.
38. Jordana M, B Sarnstrand, PJ Sime and I Ramis. (1994). Immune-inflammatory functions of fibroblasts. Eur Respir J 7:2212-2222.
39. Enzerink A and A Vaheri. (2011). Fibroblast activation in vascular inflammation. J Thromb Haemost 9:619-626.
40. Torres J and FM Watt. (2008). Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkB and cooperating with Stat3. Nat Cell Biol 10:194-201.
41. Armstrong L, O Hughes, S Yung, L Hyslop, R Stewart, I Wappler, H Peters, T Walter, P Stojkovic, et al. (2006). The role of PI3K/AKT, MAPK/ERK and NFkB signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15:1894-1913.
42. Kang HB, YE Kim, HJ Kwon, DE Sok and Y Lee. (2007). Enhancement of NFkB expression and activity upon differentiation of human embryonic stem cell line SNUhES3. Stem Cells Dev16:615-624.
43. Lee J, N Sayed, A Hunter, K Au, W Wong, E Mocarski, R Pera, E Yakubov and J Cooke. (2012). Activation of innate immunity is required for efficient nuclear reprogramming. Cell 151:547-558.
44. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito, K Nakao and S Nishikawa. (2000). Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
45. Levenberg S, JS Golub, M Amit, J Itskovitz-Eldor and R Langer. (2002). Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 99:4391-4396.
46. McCloskey KE, SL Stice and RM Nerem. (2006). In vitro derivation and expansion of endothelial cells from embryonic stem cells. Methods Mol Biol 330:287-301.
47. Blancas AA, NE Lauer and KE McCloskey. (2008). Endothelial differentiation of embryonic stem cells. Curr Protoc Stem Cell Biol Chapter 1:Unit 1F.5.
48. Sinha S, MH Hoofnagle, ME McCanna and GK Owens. (2004). Transforming growth factor-{beta}1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol 287:C1560-C1568.
49. Bell E. (2009). Innate immunity: endothelial cells as sentinels. Nat Rev Immunol 9:532-533.
50. Mai J, A Virtue, J Shen, H Wang and XF Yang. (2013). An evolving new paradigm: endothelial cells-conditional innate immune cells. J Hematol Oncol 6:61.